title: Full-dose peginterferon Alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis C patients with end-stage renal disease.
authors.forename: Mamdouh M
authors.initials: MM
authors.lastname: Abdulhadi-Ali
authors.forename: Dib
authors.initials: D
authors.lastname: Alsaudi
authors.forename: Adnan
authors.initials: A
authors.lastname: Agha
authors.forename: Nasser
authors.initials: N
authors.lastname: Ibraheem-Alqahtani
authors.forename: Manuele
authors.initials: M
authors.lastname: Furnari
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Savarino
authors.forename: Edoardo G
authors.initials: EG
authors.lastname: Giannini
mesh_terms: D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D016898:Interferon-alpha / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*
chemical_list: D007155:Immunologic Factors; D016898:Interferon-alpha; D011092:Polyethylene Glycols